Lombard Medical Limited, one of the wholly-owned subsidiaries of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (stock code: 688016.SH), acquired in 2024, is an Oxfordshire company (UK) founded in 1994 and specializes in the design and manufacturing of medical devices for the treatment of aortic disease, particularly in the area of endovascular therapies.